Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PPAR gamma | 4 | 2016 | 49 | 1.660 |
Why?
|
| Prostatic Neoplasms | 11 | 2016 | 794 | 1.480 |
Why?
|
| Thiazolidinediones | 3 | 2011 | 48 | 1.100 |
Why?
|
| Receptors, Androgen | 4 | 2022 | 122 | 0.990 |
Why?
|
| Cell Division | 7 | 2005 | 296 | 0.550 |
Why?
|
| Calcitriol | 6 | 2005 | 30 | 0.540 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2010 | 16 | 0.460 |
Why?
|
| Chromans | 2 | 2011 | 15 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2016 | 781 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2011 | 52 | 0.400 |
Why?
|
| Cell Line, Tumor | 7 | 2022 | 2128 | 0.390 |
Why?
|
| Signal Transduction | 3 | 2011 | 1802 | 0.390 |
Why?
|
| Receptors, Calcitriol | 3 | 2005 | 59 | 0.330 |
Why?
|
| Apoptosis | 7 | 2011 | 1317 | 0.320 |
Why?
|
| RNA, Messenger | 6 | 2016 | 1152 | 0.300 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 220 | 0.290 |
Why?
|
| Serpins | 2 | 2003 | 26 | 0.280 |
Why?
|
| Prostate | 5 | 2004 | 136 | 0.280 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 13 | 0.270 |
Why?
|
| Calcium Channel Agonists | 1 | 2005 | 2 | 0.270 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2005 | 3 | 0.270 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 22 | 0.270 |
Why?
|
| Vitamin D | 2 | 2005 | 176 | 0.270 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 756 | 0.270 |
Why?
|
| Dihydrotestosterone | 3 | 2016 | 26 | 0.250 |
Why?
|
| Receptor, erbB-2 | 1 | 2005 | 122 | 0.250 |
Why?
|
| Androgens | 3 | 2016 | 87 | 0.240 |
Why?
|
| Cell Proliferation | 4 | 2011 | 1149 | 0.230 |
Why?
|
| Annexin A6 | 1 | 2022 | 14 | 0.220 |
Why?
|
| Male | 15 | 2016 | 18870 | 0.210 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2023 | 214 | 0.200 |
Why?
|
| Cell Differentiation | 2 | 2003 | 562 | 0.190 |
Why?
|
| Epithelial Cells | 2 | 2003 | 366 | 0.190 |
Why?
|
| Cyclin D1 | 2 | 2010 | 42 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 4 | 2003 | 183 | 0.180 |
Why?
|
| Humans | 16 | 2023 | 34853 | 0.170 |
Why?
|
| Cell Cycle | 3 | 2011 | 309 | 0.160 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 391 | 0.160 |
Why?
|
| Retinoids | 1 | 1997 | 28 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 161 | 0.130 |
Why?
|
| Colonic Neoplasms | 1 | 1997 | 181 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 1997 | 239 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 550 | 0.110 |
Why?
|
| Gene Expression | 2 | 2010 | 639 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2005 | 490 | 0.100 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 19 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2009 | 54 | 0.100 |
Why?
|
| Androgen-Binding Protein | 1 | 2010 | 2 | 0.100 |
Why?
|
| Transfection | 2 | 2010 | 496 | 0.100 |
Why?
|
| Genes, Reporter | 1 | 2010 | 132 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2010 | 95 | 0.090 |
Why?
|
| HIV Infections | 1 | 2023 | 2207 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 152 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2011 | 878 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 4 | 2004 | 480 | 0.070 |
Why?
|
| Gene Expression Regulation | 2 | 2003 | 968 | 0.070 |
Why?
|
| Mutation | 1 | 2010 | 1023 | 0.070 |
Why?
|
| Animals | 8 | 2004 | 14307 | 0.070 |
Why?
|
| cdc25 Phosphatases | 1 | 2005 | 5 | 0.070 |
Why?
|
| Acid Phosphatase | 1 | 2005 | 19 | 0.070 |
Why?
|
| Phosphotyrosine | 1 | 2005 | 24 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2005 | 420 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2003 | 91 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2005 | 65 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2005 | 97 | 0.070 |
Why?
|
| Growth Substances | 1 | 2004 | 16 | 0.060 |
Why?
|
| Tennessee | 1 | 2023 | 59 | 0.060 |
Why?
|
| Phorbol Esters | 1 | 2003 | 8 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 24 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2003 | 43 | 0.060 |
Why?
|
| G1 Phase | 1 | 2003 | 32 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 66 | 0.060 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 13 | 0.060 |
Why?
|
| Rats | 4 | 2003 | 3261 | 0.050 |
Why?
|
| Schools | 1 | 2023 | 229 | 0.050 |
Why?
|
| Oxygen | 1 | 2022 | 193 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 217 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 200 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 416 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1999 | 24 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1999 | 68 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2003 | 1442 | 0.040 |
Why?
|
| Students | 1 | 2023 | 452 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1999 | 166 | 0.040 |
Why?
|
| Benzoates | 1 | 1997 | 15 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1997 | 25 | 0.040 |
Why?
|
| Progesterone | 1 | 1997 | 117 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 1997 | 72 | 0.040 |
Why?
|
| Mice | 4 | 2004 | 5668 | 0.040 |
Why?
|
| Risk Factors | 1 | 2004 | 3414 | 0.030 |
Why?
|
| Cell Line | 3 | 2002 | 1289 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2000 | 323 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2004 | 1 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2004 | 22 | 0.020 |
Why?
|
| Thymidine | 1 | 2004 | 15 | 0.020 |
Why?
|
| Retinoid X Receptors | 1 | 2004 | 11 | 0.020 |
Why?
|
| COS Cells | 1 | 2004 | 62 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2004 | 65 | 0.020 |
Why?
|
| Caspases | 1 | 2004 | 132 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2004 | 423 | 0.010 |
Why?
|
| Cyclins | 1 | 2003 | 35 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2003 | 32 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2004 | 287 | 0.010 |
Why?
|
| Tretinoin | 1 | 2003 | 50 | 0.010 |
Why?
|
| Fibrinolysin | 1 | 2002 | 8 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2003 | 171 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 484 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 338 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 139 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 249 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 984 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 310 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 605 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 87 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 1124 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 1490 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2002 | 751 | 0.010 |
Why?
|
| Finasteride | 1 | 1998 | 3 | 0.010 |
Why?
|
| Flutamide | 1 | 1998 | 7 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 600 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 1998 | 19 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 485 | 0.010 |
Why?
|
| Antibodies | 1 | 1998 | 135 | 0.010 |
Why?
|
| Testosterone | 1 | 1998 | 181 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 445 | 0.010 |
Why?
|